Media Pack
News

Current Edition

Volume 16 Issue 2
 
In Pursuit of eConsent: Best Practice Recommendations for Successful Integration
Editorial Archive

In Pursuit of eConsent: Best Practice Recommendations for Successful Integration

Electronic informed consent (eConsent) solutions have been introduced in recent years, representing a major advancement in improving information delivery to study par...
10 April 2017 Editorial Archive | Volume 9 Issue 2
Continue Reading →
Clinical Development in Challenging Cancers: Adrenocortical Carcinoma
Editorial Archive

Clinical Development in Challenging Cancers: Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare cancer with an estimated incidence of 1 to 2 patients per million people annually. About 50%–70% of adrenal cancers are funct...
10 April 2017 Editorial Archive | Volume 9 Issue 2
Continue Reading →
Companies Need More Awareness of EU Pediatric Investigation Plans (PIPs)
Editorial Archive

Companies Need More Awareness of EU Pediatric Investigation Plans (PIPs)

Pediatric legislation was introduced based on the American Academy of Pediatrics (AAP) concerns that children did not participate sufficiently in therapeutic progress...
10 April 2017 Editorial Archive | Volume 9 Issue 2
Continue Reading →
Constructing Composites to Optimise Cognitive Outcomes
Editorial Archive

Constructing Composites to Optimise Cognitive Outcomes

Henry J. Riordan, Ph.D., Executive Vice President of Medical and Scientific Affairs and Global Lead for Neuroscience at Worldwide Clinical Trials, shares his views on...
10 April 2017 Editorial Archive | Volume 9 Issue 2
Continue Reading →
Clinical Trials in Central and Eastern Europe: Keeping Up with Global Competition
Editorial Archive

Clinical Trials in Central and Eastern Europe: Keeping Up with Global Competition

A great number of willing patients, highly experienced researchers and EMA-compliant legislation make the CEE region an attractive research site destination. The data...
10 April 2017 Editorial Archive | Volume 9 Issue 2
Continue Reading →
Clinical Trial Enrolment in China: The Potential Role of Patient Advocacy Groups and Digital Health Networks
Editorial Archive

Clinical Trial Enrolment in China: The Potential Role of Patient Advocacy Groups and Digital Health Networks

China has a large and vibrant ecosystem of patient advocacy groups and digital health networks that provides clinical trial sponsors with opportunities to engage and ...
10 April 2017 Editorial Archive | Volume 9 Issue 2
Continue Reading →
Risk-based Monitoring: The Innovative Model Redefining Clinical Trial Risk Management
Editorial Archive

Risk-based Monitoring: The Innovative Model Redefining Clinical Trial Risk Management

One area in the clinical trial process that has been identified for improvement is risk-based planning and management. Monitoring and managing risk has always been a ...
10 April 2017 Editorial Archive | Volume 9 Issue 2
Continue Reading →
CDISC for Non-Experts Everything You Always Wanted to Know About CDISC (But Were Afraid to Ask)
Editorial Archive

CDISC for Non-Experts Everything You Always Wanted to Know About CDISC (But Were Afraid to Ask)

CDSIC is meant to enable you to collect, store and transfer clinical data in a way that makes them easily usable on a large scale in an unambiguous way. Collecting da...
10 April 2017 Editorial Archive | Volume 9 Issue 2
Continue Reading →
The Challenges and Benefits of Biosimilar Drug Development for Trastuzumab, a Precision Medicine
Editorial Archive

The Challenges and Benefits of Biosimilar Drug Development for Trastuzumab, a Precision Medicine

Monoclonal antibodies (mAb) are among the most promising biologic drugs currently on the market for treatment of life-threatening diseases. The selectivity and specif...
10 April 2017 Editorial Archive | Volume 9 Issue 2
Continue Reading →
Pharmacovigilance’s Growing Influence
Editorial Archive

Pharmacovigilance’s Growing Influence

Pharmacovigilance will always be about protecting patients. The discipline is rapidly evolving into something greater than regulatory compliance; increasingly, pharma...
10 April 2017 Editorial Archive | Volume 9 Issue 2
Continue Reading →
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte